CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
暂无分享,去创建一个
Fabian Kiessling | Felix Gremse | Christian Trautwein | Twan Lammers | Tom Luedde | Josef Ehling | Diana Möckel | Frank Tacke | T. Luedde | F. Tacke | C. Trautwein | F. Kiessling | T. Lammers | D. Eulberg | J. Ehling | F. Gremse | K. Hittatiya | Dirk Eulberg | D. Möckel | Matthias Bartneck | Xiao Wei | Viktor Fech | Christer Baeck | Kanishka Hittatiya | M. Bartneck | Xiao Wei | V. Fech | Christer Baeck
[1] D. Wendum,et al. Hypoxia‐induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis , 2002, Hepatology.
[2] Fabian Kiessling,et al. Micro-CT Imaging of Tumor Angiogenesis Quantitative Measures Describing Micromorphology and Vascularization , 2014 .
[3] P. Allavena,et al. Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation , 2009, Journal of leukocyte biology.
[4] Steffen Jung,et al. On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells , 2013, The Journal of experimental medicine.
[5] O. Rosmorduc,et al. Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. , 2010, Seminars in liver disease.
[6] T. Luedde,et al. Chemokine receptor CCR6‐dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis , 2014, Hepatology.
[7] F. Sánchez‐Madrid,et al. Angiogenesis in chronic inflammatory liver disease , 2004, Hepatology.
[8] Laurent Castera,et al. Noninvasive methods to assess liver disease in patients with hepatitis B or C. , 2012, Gastroenterology.
[9] F. Tacke. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo , 2012, Fibrogenesis & tissue repair.
[10] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[11] Fabian Kiessling,et al. Non-invasive imaging for studying anti-angiogenic therapy effects , 2013, Thrombosis and Haemostasis.
[12] B. Tura,et al. Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats , 2010, BMC veterinary research.
[13] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[14] P. Carmeliet,et al. Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats , 2007, Hepatology.
[15] Yongming Dai,et al. Gamna-Gandy Bodies of the Spleen Detected with Susceptibility Weighted Imaging: Maybe a New Potential Non-Invasive Marker of Esophageal Varices , 2013, PloS one.
[16] A. Tessitore,et al. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages , 2012, BioMed research international.
[17] T. Luedde,et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury , 2011, Gut.
[18] C. Ng,et al. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease , 2004, European journal of gastroenterology & hepatology.
[19] P. Carmeliet,et al. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models , 2013, Hepatology.
[20] C. Lewis,et al. Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.
[21] T. Luedde,et al. The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes , 2010, Hepatology.
[22] Ralph Sinkus,et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. , 2008, Gastroenterology.
[23] J. Fallowfield,et al. Edinburgh Research Explorer Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Differential Ly-6C expression identi fi es the recruited macrophage phenotype, which orchestrates the regression of murine liver fi brosis , 2022 .
[24] H. Nagano,et al. TIE2‐expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis , 2013, Hepatology.
[25] D. Schuppan,et al. Evolving therapies for liver fibrosis. , 2013, The Journal of clinical investigation.
[26] S. Friedman,et al. Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo , 2012, Digestive Diseases and Sciences.
[27] Lan Wei,et al. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. , 2012, Journal of hepatology.
[28] René M. Botnar,et al. Elastin‐based molecular MRI of liver fibrosis , 2013, Hepatology.
[29] F. Ginhoux,et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis , 2009, Hepatology.
[30] Fabian Kiessling,et al. Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography. , 2011, Radiology.
[31] S. Coulon,et al. Angiogenesis in chronic liver disease and its complications , 2011, Liver international : official journal of the International Association for the Study of the Liver.